⇄

1 Article(s) Download
	PMID	Title	Pub. Year	#Total Relationships
1	33598678	BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.	2021 Jun 24	1